Effects of olmesartan on renal and cardiovascular outcomes in type 2 diabetes with overt nephropathy: a multicentre, randomised, placebo-controlled study

Nav

General Info

Geography

Japan (JPN)

Time period covered

01/2003 - 12/2005

Data type

Scientific literature

Keywords

Blood pressure

Citation

Authors

Imai E, Chan JC, Ito S, Yamasaki T, Kobayashi F, Haneda M, Makino H, ORIENT study investigators

Journal

Diabetologia

Volume

Issue

Pages

2978-86

Publication year

2011

Suggested citation

Imai E, Chan JC, Ito S, Yamasaki T, Kobayashi F, Haneda M, Makino H, ORIENT study investigators. Effects of olmesartan on renal and cardiovascular outcomes in type 2 diabetes with overt nephropathy: a multicentre, randomised, placebo-controlled study. Diabetologia. 2011; 54(12): 2978-86.

DOI

10.1007/s00125-011-2325-z

PMID

21993710

GHDx Entry last modified on: May 30, 2020

Header sites

Search form

Main menu

Effects of olmesartan on renal and cardiovascular outcomes in type 2 diabetes with overt nephropathy: a multicentre, randomised, placebo-controlled study

Nav